(Q33805835)

29 July 2017

1 reference

title

Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors (English)

1 reference

29 July 2017

Sugrue MF

1

1 reference

29 July 2017

publication date

1 January 2000

1 reference

Progress in Retinal and Eye Research

29 July 2017

published in

1 reference

29 July 2017

volume

19

1 reference

29 July 2017

issue

1

1 reference

29 July 2017

page(s)

87-112

1 reference

Medical Management of Glaucoma

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Thienothiopyran-2-sulfonamides: novel topically active carbonic anhydrase inhibitors for the treatment of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Validation of a questionnaire for comparing the tolerability of ophthalmic medications.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Decrease in intraocular pressure in man by a carbonic anhydrase inhibitor, diamox; a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Structural analysis of inhibitor binding to human carbonic anhydrase II

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

A randomized trial comparing the dorzolamide-timolol combination given twice daily to monotherapy with timolol and dorzolamide. Dorzolamide-Timolol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The presentation and prognosis of glaucoma in pseudoexfoliation of the lens capsule

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Comparative effects of intraocular pressure between systemic and topical carbonic anhydrase inhibitors: a clinical masked, cross-over study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

A randomized trial in patients inadequately controlled with timolol alone comparing the dorzolamide-timolol combination to monotherapy with timolol or dorzolamide. Dorzolamide-Timolol Combination Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Sulfonamides do not reach the retina in therapeutic amounts after topical application to the cornea

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Treatment of Chronic Macular Edema With Acetazolamide

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Carbonic anhydrase inhibitor side effects. Serum chemical analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Acetazolamide for treatment of chronic macular edema in retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Optic nerve blood-flow abnormalities in glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The relation between carbonic anhydrase activity and ion transport in elasmobranch and rabbit lens

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

A clinical trial of MK-507, Trusopt, for raised intraocular pressure--the Australian experience

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Diamox (acetazoleamide) in treatment of glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Effects of locally administered diamox

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Efficacy of dorzolamide hydrochloride in the management of chronic cystoid macular edema in patients with retinitis pigmentosa

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Effects of dorzolamide hydrochloride 2% on the retinal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Two topical carbonic anhydrase inhibitors sezolamide and dorzolamide in Gelrite vehicle: a multiple-dose efficacy study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Localization of carbonic anhydrase IV in a specific capillary bed of the human eye

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Assessment of human ocular hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Effects of topical dorzolamide on retinal and retrobulbar hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

CO2 dependence of retinal arterial and capillary blood velocity

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Dorzolamide, visual function and ocular hemodynamics in normal-tension glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The efficacy of dorzolamide, a topical carbonic anhydrase inhibitor, in combination with timolol in the treatment of patients with open-angle glaucoma and ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Acute effects of acetazolamide on cerebral blood flow in man

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

A comparison of dorzolamide and timolol in patients with pseudoexfoliation and glaucoma or ocular hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Comparison of the safety and efficacy of the fixed combination of dorzolamide/timolol and the concomitant administration of dorzolamide and timolol: a clinical equivalence study. International Clinical Equivalence Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

A comparison of the efficacy and tolerability of dorzolamide and acetazolamide as adjunctive therapy to timolol. Oral to Topical CAI Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Glaucoma: diagnosis and management

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Influence of dorzolamide on corneal thickness, endothelial cell count and corneal sensibility.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Irreversible corneal decompensation in patients treated with topical dorzolamide

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Failure of acetazolamide to decrease intraocular pressure in patients with carbonic anhydrase II deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Effects of ambient bicarbonate, phosphate and carbonic anhydrase inhibitors on fluid transport across rabbit corneal endothelium

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Topical 2.0% dorzolamide vs oral acetazolamide for prevention of intraocular pressure rise after neodymium:YAG laser posterior capsulotomy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Dorzolamide versus pilocarpine as adjunctive therapies to timolol: a comparison of patient preference and impact on daily life

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Aqueous humor flow in human eyes treated with dorzolamide and different doses of acetazolamide

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

A double-masked, randomized, 1-year study comparing the corneal effects of dorzolamide, timolol, and betaxolol. Dorzolamide Corneal Effects Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Pharmacological testing in the laser-induced monkey glaucoma model

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Structure and mechanism of carbonic anhydrase

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

MK-507 versus sezolamide. Comparative efficacy of two topically active carbonic anhydrase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Dose response and duration of action of dorzolamide, a topical carbonic anhydrase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Carbonic anhydrase: chemistry, physiology, and inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Ocular absorption, blood levels, and excretion of dorzolamide, a topically active carbonic anhydrase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The location of the fluid pump in the cornea

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Comparison of dorzolamide and acetazolamide as suppressors of aqueous humor flow in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Acetazolamide but not timolol lowers aqueous humor flow in sleeping humans

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Continuous intraocular pressure measurement by telemetry in alpha-chymotrypsin-induced glaucoma model in the rabbit: effects of timolol, dorzolamide, and epinephrine

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Dorzolamide: development and clinical application of a topical carbonic anhydrase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

1 reference

7 January 2021

Number of people with glaucoma worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The effect of acetazolamide on the retinal circulation

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Combination of systemic acetazolamide and topical dorzolamide in reducing intraocular pressure and aqueous humor formation.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Gelrite®: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Comparison of the efficacy and safety of 2% dorzolamide and 0.5% betaxolol in the treatment of elevated intraocular pressure. Dorzolamide Comparison Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Topical carbonic anhydrase inhibition increases ocular pulse amplitude in high tension primary open angle glaucoma

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The effects of apraclonidine on conjunctival oxygen tension

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Clinical efficacy and safety of brinzolamide (Azopt), a new topical carbonic anhydrase inhibitor for primary open-angle glaucoma and ocular hypertension. Brinzolamide Primary Therapy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Human carbonic anhydrases and carbonic anhydrase deficiencies

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Positions of His-64 and a bound water in human carbonic anhydrase II upon binding three structurally related inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Dorzolamide hydrochloride and visual function in normal eyes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Structures of murine carbonic anhydrase IV and human carbonic anhydrase II complexed with brinzolamide: molecular basis of isozyme-drug discrimination

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

A double-masked, randomized 1-year study comparing dorzolamide (Trusopt), timolol, and betaxolol. International Dorzolamide Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The efficacy and safety of the dorzolamide-timolol combination versus the concomitant administration of its components. Dorzolamide-Timolol Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The preclinical pharmacology of dorzolamide hydrochloride, a topical carbonic anhydrase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

New approaches to antiglaucoma therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

A comparison of L-671,152 and MK-927, two topically effective ocular hypotensive carbonic anhydrase inhibitors, in experimental animals

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Carbonic anhydrase inhibitors: inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Treatment of chronic open-angle glaucoma associated with pseudoexfoliation

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The epidemiology and control of open angle glaucoma: a population-based perspective

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Combined effect of dorzolamide and latanoprost on the rate of aqueous humor flow

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

The ocular hypotensive effect of the topical carbonic anhydrase inhibitor L-671,152 in glaucomatous monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

MK-507 (L-671,152), a topically active carbonic anhydrase inhibitor, reduces aqueous humor production in monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Additive effect of dorzolamide on aqueous humor flow in patients receiving long-term treatment with timolol.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Comparison of dorzolamide and timolol as suppressors of aqueous humor flow in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Four-week safety and efficacy study of dorzolamide, a novel, active topical carbonic anhydrase inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Ocular blood flow measurement.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

Cytoplasmic pH responses to carbonic anhydrase inhibitors in cultured rabbit nonpigmented ciliary epithelium.

1 reference

https://api.crossref.org/works/10.1016%2FS1350-9462%2899%2900006-3

7 January 2021

10.1016/S1350-9462(99)00006-3

Identifiers

DOI

1 reference

29 July 2017

1 reference